107 related articles for article (PubMed ID: 15954382)
41. [An overview of the 10(th) International Kawasaki Disease Symposium].
Chen SB; Huang MR
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):714-7. PubMed ID: 23158827
[No Abstract] [Full Text] [Related]
42. Adolescent Kawasaki disease with uveitis.
Callaway LK; Bennett CJ
Intern Med J; 2002 Aug; 32(8):421-2. PubMed ID: 12162401
[No Abstract] [Full Text] [Related]
43. Superantigens and Kawasaki disease.
Furukawa S; Matsubara T; Yabuta K
Immunol Today; 1991 Dec; 12(12):464. PubMed ID: 1786081
[No Abstract] [Full Text] [Related]
44. Summarizing What Has Been Learned About Kawasaki Disease.
Moreno MA
JAMA Pediatr; 2016 Nov; 170(11):1124. PubMed ID: 27820626
[No Abstract] [Full Text] [Related]
45. [Kawasaki disease: what's new in 2012?].
Piram M; Koné-Paut I
Arch Pediatr; 2012 Oct; 19(10):1012-4. PubMed ID: 22939648
[No Abstract] [Full Text] [Related]
46. Kawasaki disease: a review.
Gerding R
J Pediatr Health Care; 2011; 25(6):379-87. PubMed ID: 22018429
[No Abstract] [Full Text] [Related]
47. Kawasaki syndrome.
Mills MD; Smith LB
Int Ophthalmol Clin; 1992; 32(1):81-92. PubMed ID: 1537667
[No Abstract] [Full Text] [Related]
48. Streptococcal-induced Kawasaki disease of the psoriasiform phenotype in a young adult.
Georgesen C; Ladak K; Harp J; Magro C
Int J Dermatol; 2017 Sep; 56(9):965-967. PubMed ID: 28718879
[No Abstract] [Full Text] [Related]
49. [Kawasaki disease: an infectious disease?].
Cimaz R
Rev Med Interne; 2005 Oct; 26 Spec No 1():15-8. PubMed ID: 16475258
[No Abstract] [Full Text] [Related]
50. Kawasaki syndrome.
Meissner HC; Leung DY
Curr Opin Rheumatol; 1995 Sep; 7(5):455-8. PubMed ID: 8519621
[TBL] [Abstract][Full Text] [Related]
51. Oedema over an inoculation site.
Ng NBH; Ramachandran R
BMJ; 2020 Jan; 368():l6823. PubMed ID: 31948944
[No Abstract] [Full Text] [Related]
52. [Kawasaki disease: basis of the streptococcal theory (proposed by Ueno and Matsumi), with a rebuttal to its critique].
Matsumi F; Ueno T
Nihon Rinsho; 1983 Sep; 41(9):2063-8. PubMed ID: 6363752
[No Abstract] [Full Text] [Related]
53. Superantigens, conventional antigens and the etiology of Kawasaki syndrome.
Meissner HC; Leung DY
Pediatr Infect Dis J; 2000 Feb; 19(2):91-4. PubMed ID: 10693992
[No Abstract] [Full Text] [Related]
54. Superantigens related to Kawasaki syndrome.
Leung DY
Springer Semin Immunopathol; 1996; 17(4):385-96. PubMed ID: 8966663
[No Abstract] [Full Text] [Related]
55. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease.
Jibiki T; Terai M; Shima M; Ogawa A; Hamada H; Kanazawa M; Yamamoto S; Oana S; Kohno Y
Arthritis Rheum; 2001 Sep; 44(9):2211-2. PubMed ID: 11592387
[No Abstract] [Full Text] [Related]
56. New developments in the search for the etiologic agent of Kawasaki disease.
Rowley AH; Shulman ST
Curr Opin Pediatr; 2007 Feb; 19(1):71-4. PubMed ID: 17224665
[TBL] [Abstract][Full Text] [Related]
57. Continuous Hemofiltration Plus Plasma Exchange in Patient with Kawasaki Disease Shock Syndrome: A Case Report and Literature Review.
Miao H; Cui Y; Wang F; Zhang Y; Wang C
Ann Clin Lab Sci; 2019 Nov; 49(6):829-834. PubMed ID: 31882435
[TBL] [Abstract][Full Text] [Related]
58. Management of Kawasaki disease.
Shulman ST
J Pediatr; 1988 Dec; 113(6):1116-7. PubMed ID: 3193319
[No Abstract] [Full Text] [Related]
59. Bacterial toxin-induced cytokine production studied at the single-cell level.
Andersson J; Nagy S; Björk L; Abrams J; Holm S; Andersson U
Immunol Rev; 1992 Jun; 127():69-96. PubMed ID: 1506008
[No Abstract] [Full Text] [Related]
60. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease.
Nagata S; Yamashiro Y; Ohtsuka Y; Shimizu T; Sakurai Y; Misawa S; Ito T
Immunology; 2009 Dec; 128(4):511-20. PubMed ID: 19950419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
